BACKGROUND AND PURPOSEProtein isoprenylation is an important step in the intracellular signalling pathway conducting cell growth and differentiation. In bone, protein isoprenylation is required for osteoclast differentiation and activation. However, its role in osteoblast differentiation and function remains unknown. In this study, we assessed the role of protein isoprenylation in osteoblastogenesis in a model of mesenchymal stem cells (MSC) differentiation.
EXPERIMENTAL APPROACHWe tested the effect of an inhibitor of farnesylation [farnesyl transferase inhibitor-277 (FTI-277)] and one of geranylgeranylation [geranylgeranyltransferase inhibitor-298 (GGTI-298)] on osteoblast differentiating MSC. In addition, we tested the effect of alendronate on protein isoprenylation in this model either alone or in combination with other inhibitors of isoprenylation.
KEY RESULTSInitially, we found that levels of unfarnesylated proteins (prelamin A and HDJ-2) increased after treatment with FTI-277 concomitantly affecting osteoblastogenesis and increasing nuclear morphological changes without affecting cell survival. Furthermore, inhibition of geranylgeranylation by GGTI-298 alone increased osteoblastogenesis. This effect was enhanced by the combination of GGTI-298 and alendronate in the osteogenic media.
CONCLUSIONS AND IMPLICATIONSOur data indicate that both farnesylation and geranylgeranylation play a role in osteoblastogenesis. In addition, a new mechanism of action for alendronate on protein isoprenylation in osteogenic differentiating MSC in vitro was found. In conclusion, protein isoprenylation is an important component of the osteoblast differentiation process that could constitute a new therapeutic target for osteoporosis in the future.
AbbreviationsALP, alkaline phosphatase; EDTA, ethylenediamine tetra-acetic acid; EGTA, ethylene glycol tetraacetic acid; FCS, fetal calf serum; FTI, farnesyl transferase inhibitor; GGPP, geranylgeranyl-pyrophosphate; MSC, mesenchymal stem cells; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium; OCN, osteocalcin; OIM, osteoblastogenesis induction media; pNPP, p-nitrophenyl phosphate; RAP-1, ras-like protein 1; RUNX2, runt-related transcription factor 2; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labelling BJP British Journal of Pharmacology